Toronto - Delayed Quote CAD
Oncolytics Biotech Inc. (ONC.TO)
At close: October 18 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 6 | 7 |
| Avg. Estimate | -0.1 | -0.1 | -0.4 | -0.42 |
| Low Estimate | -0.11 | -0.12 | -0.44 | -0.5 |
| High Estimate | -0.09 | -0.08 | -0.36 | -0.32 |
| Year Ago EPS | -0.14 | -0.05 | -0.41 | -0.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | 860k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 6M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.1 | -0.15 | -0.11 | -0.1 |
| EPS Actual | -0.14 | -0.05 | -0.09 | -0.1 |
| Difference | -0.04 | 0.1 | 0.02 | 0 |
| Surprise % | -40.00% | 66.70% | 18.20% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.1 | -0.4 | -0.42 |
| 7 Days Ago | -0.1 | -0.1 | -0.4 | -0.42 |
| 30 Days Ago | -0.1 | -0.1 | -0.4 | -0.42 |
| 60 Days Ago | -0.1 | -0.1 | -0.4 | -0.42 |
| 90 Days Ago | -0.11 | -0.1 | -0.4 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ONC.TO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 28.60% | -- | -- | 3.70% |
| Next Qtr. | -100.00% | -- | -- | 7.90% |
| Current Year | 2.40% | -- | -- | 2.50% |
| Next Year | -5.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Initiated | Raymond James: Outperform | 4/4/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/14/2024 |
Related Tickers
MDNA.TO Medicenna Therapeutics Corp.
2.2800
-3.39%
BCT.TO BriaCell Therapeutics Corp.
1.1600
0.00%
TH.TO Theratechnologies Inc.
1.8300
+3.98%
APS.TO Aptose Biosciences Inc.
0.5500
+10.00%
SVA.TO Sernova Corp.
0.2650
0.00%
BCTXW BriaCell Therapeutics Corp.
0.3105
+3.16%
MBX.TO Microbix Biosystems Inc.
0.3350
0.00%
APLI.TO Appili Therapeutics Inc.
0.0400
+14.29%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
MDNAF Medicenna Therapeutics Corp.
1.6460
-0.84%